Becker Capital Management Inc Gilead Sciences, Inc. Transaction History

Becker Capital Management Inc

$3.04 Billion
Q3 2024

A detailed history of Becker Capital Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Becker Capital Management Inc holds 16,944 shares of GILD stock, worth $1.57 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,944

Previous 17,280 1.94%

Holding current value

$1.57 Million

Previous $1.19 Million 19.83%

% of portfolio

0.05%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $22,374 - $28,220	-336 Reduced 1.94%	16,944 $1.42 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $116,196 - $134,099	-1,840 Reduced 9.62%	17,280 $1.19 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $164,920 - $201,116	-2,304 Reduced 10.75%	19,120 $1.4 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $97,009 - $110,011	-1,324 Reduced 5.82%	21,424 $1.74 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $441,717 - $481,922	-5,974 Reduced 20.8%	22,748 $1.7 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $616,517 - $703,223	-8,111 Reduced 22.02%	28,722 $2.21 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $8.68 Million - $9.89 Million	-112,280 Reduced 75.3%	36,833 $3.06 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $6.75 Million - $9.69 Million	-108,303 Reduced 42.07%	149,113 $12.8 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $445,359 - $508,714	-7,480 Reduced 2.82%	257,416 $15.9 Million
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $6.69 Million - $7.53 Million	-115,836 Reduced 30.42%	264,896 $16.4 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $12,568 - $15,749	-217 Reduced 0.06%	380,732 $22.6 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $1.31 Million - $1.48 Million	-20,136 Reduced 5.02%	380,949 $27.7 Million
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $2.47 Million - $2.67 Million	36,499 Added 10.01%	401,085 $28 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $130,303 - $142,375	2,053 Added 0.57%	364,586 $25.1 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $84,960 - $96,939	1,416 Added 0.39%	362,533 $23.4 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1.06 Million - $1.21 Million	-18,722 Reduced 4.93%	361,117 $21 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $463,452 - $582,711	-7,463 Reduced 1.93%	379,839 $24 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $7.49 Million - $8.7 Million	-103,518 Reduced 21.09%	387,302 $29.8 Million
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $12.1 Million - $15.5 Million	-193,012 Reduced 28.23%	490,820 $36.7 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $6.28 Million - $6.9 Million	101,863 Added 17.5%	683,832 $44.4 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $9.77 Million - $10.8 Million	-156,325 Reduced 21.17%	581,969 $36.9 Million
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $367,198 - $411,770	5,935 Added 0.81%	738,294 $49.9 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $255,497 - $286,224	4,086 Added 0.56%	732,359 $47.6 Million
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $1.25 Million - $1.63 Million	-20,585 Reduced 2.75%	728,273 $45.6 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $149,688 - $165,732	-2,100 Reduced 0.28%	748,858 $57.8 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $1.23 Million - $1.43 Million	18,918 Added 2.58%	750,958 $53.2 Million
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $2.28 Million - $2.78 Million	31,270 Added 4.46%	732,040 $55.2 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $159,304 - $187,001	-2,239 Reduced 0.32%	700,770 $50.2 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $1.08 Million - $1.28 Million	15,030 Added 2.18%	703,009 $57 Million
Q2 2017 Aug 11, 2017	BUY	N/A	687,979	687,979 $48.7 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.

Account

Becker Capital Management Inc Gilead Sciences, Inc. Transaction History